Vimarsana
Biggest News Aggregation in the World

Page 6 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

Critical Comparison: Oncology Pharma (OTCMKTS:ONPH) vs. DocuSign (NASDAQ:DOCU) - Vimarsana News

Critical Comparison: Oncology Pharma (OTCMKTS:ONPH) vs. DocuSign (NASDAQ:DOCU)

Oncology Pharma (OTCMKTS:ONPH – Get Free Report) and DocuSign (NASDAQ:DOCU – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends. Analyst Recommendations This is a summary of recent ratings […]

Acasti Pharma (NASDAQ:ACST) Stock Crosses Above Two Hundred Day Moving Average of $2.77 - Vimarsana News

Acasti Pharma (NASDAQ:ACST) Stock Crosses Above Two Hundred Day Moving Average of $2.77

Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.77 and traded as high as $2.80. Acasti Pharma shares last traded at $2.70, with a volume of 15,108 shares. Analyst Upgrades and Downgrades Separately, Craig […]

Short Interest in Astellas Pharma Inc. (OTCMKTS:ALPMY) Rises By 20.2% - Vimarsana News

Short Interest in Astellas Pharma Inc. (OTCMKTS:ALPMY) Rises By 20.2%

Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Free Report) was the recipient of a large growth in short interest in April. As of April 30th, there was short interest totalling 83,900 shares, a growth of 20.2% from the April 15th total of 69,800 shares. Based on an average trading volume of 1,006,700 shares, the days-to-cover ratio […]

MEI Pharma (NASDAQ:MEIP) Coverage Initiated at StockNews.com - Vimarsana News

MEI Pharma (NASDAQ:MEIP) Coverage Initiated at StockNews.com

Analysts at StockNews.com began coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Free Report) in a report issued on Tuesday. The brokerage set a “buy” rating on the stock. Other equities analysts have also issued research reports about the company. TheStreet lowered MEI Pharma from a “c-” rating to a “d+” rating in a […]

Investment Analysts' Recent Ratings Updates for IGC Pharma (IGC) - Vimarsana News

Investment Analysts' Recent Ratings Updates for IGC Pharma (IGC)

IGC Pharma (NYSEAMERICAN: IGC) has recently received a number of price target changes and ratings updates: 5/6/2024 – IGC Pharma is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 4/30/2024 – IGC Pharma is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 4/24/2024 […]

Source: wkrb13.com